Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Inventory (2022 - 2024)

Whitehawk Therapeutics (WHWK) has disclosed Inventory for 3 consecutive years, with $5.3 million as the latest value for Q4 2024.

  • Quarterly Inventory fell 17.36% to $5.3 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2024, down 17.36% year-over-year, with the annual reading at $5.3 million for FY2024, 17.36% down from the prior year.
  • Inventory for Q4 2024 was $5.3 million at Whitehawk Therapeutics, down from $5.5 million in the prior quarter.
  • The five-year high for Inventory was $6.4 million in Q4 2023, with the low at $202000.0 in Q1 2022.
  • Average Inventory over 3 years is $3.6 million, with a median of $3.7 million recorded in 2023.
  • The sharpest move saw Inventory soared 1782.67% in 2023, then decreased 17.36% in 2024.
  • Over 3 years, Inventory stood at $1.9 million in 2022, then surged by 245.35% to $6.4 million in 2023, then decreased by 17.36% to $5.3 million in 2024.
  • According to Business Quant data, Inventory over the past three periods came in at $5.3 million, $5.5 million, and $6.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.